Prosight Management as of Dec. 31, 2017
Portfolio Holdings for Prosight Management
Prosight Management holds 29 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Allergan | 11.8 | $16M | 98k | 163.58 | |
| Macrogenics (MGNX) | 8.5 | $12M | 608k | 19.00 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 8.2 | $11M | 1.6M | 6.80 | |
| Eiger Biopharmaceuticals | 7.0 | $9.5M | 679k | 13.95 | |
| Sabra Health Care REIT (SBRA) | 5.5 | $7.5M | 402k | 18.77 | |
| Centene Corporation (CNC) | 5.3 | $7.2M | 71k | 100.87 | |
| Chimerix (CMRX) | 5.0 | $6.8M | 1.5M | 4.63 | |
| Achaogen | 4.5 | $6.1M | 571k | 10.74 | |
| Uniqure Nv (QURE) | 4.1 | $5.6M | 285k | 19.59 | |
| Almost Family | 3.7 | $5.0M | 91k | 55.35 | |
| Reata Pharmaceuticals Inc Cl A | 3.6 | $4.9M | 173k | 28.32 | |
| Quotient | 3.4 | $4.6M | 933k | 4.95 | |
| Ignyta | 3.4 | $4.6M | 171k | 26.70 | |
| Iovance Biotherapeutics (IOVA) | 3.0 | $4.1M | 507k | 8.00 | |
| Endologix | 2.6 | $3.5M | 656k | 5.35 | |
| Radius Health | 2.6 | $3.5M | 110k | 31.77 | |
| Paratek Pharmaceuticals | 2.4 | $3.2M | 179k | 17.90 | |
| AVEO Pharmaceuticals | 2.2 | $3.0M | 1.1M | 2.79 | |
| Nabriva Therapeutics | 2.2 | $2.9M | 491k | 5.98 | |
| Clovis Oncology | 2.0 | $2.7M | 40k | 68.00 | |
| Bellicum Pharma | 1.9 | $2.5M | 301k | 8.41 | |
| Ultragenyx Pharmaceutical (RARE) | 1.5 | $2.1M | 45k | 46.39 | |
| Dex (DXCM) | 1.3 | $1.8M | 31k | 57.38 | |
| On Assignment | 1.2 | $1.7M | 26k | 64.28 | |
| Lipocine | 0.9 | $1.3M | 373k | 3.44 | |
| Conformis | 0.7 | $952k | 400k | 2.38 | |
| Noveliontherapeuti.. | 0.7 | $925k | 297k | 3.12 | |
| Acadia Healthcare (ACHC) | 0.7 | $878k | 27k | 32.62 | |
| Adamas Pharmaceuticals | 0.3 | $407k | 12k | 33.92 |
